Virtu KCG Holdings’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-58,500
Closed -$7.01M 4252
2015
Q4
$7.01M Sell
58,500
-31,400
-35% -$3.63M 0.12% 90
2015
Q3
$9.72M Buy
89,900
+37,800
+73% +$4.69M 0.16% 58
2015
Q2
$6.03M Sell
52,100
-8,600
-14% -$983K 0.11% 97
2015
Q1
$7M Sell
60,700
-38,500
-39% -$4.6M 0.14% 69
2014
Q4
$11.1M Buy
99,200
+5,700
+6% +$601K 0.18% 44
2014
Q3
$8.86M Buy
93,500
+32,200
+53% +$2.91M 0.17% 60
2014
Q2
$5.26M Sell
61,300
-116,700
-66% -$8.87M 0.08% 164
2014
Q1
$12.4M Buy
178,000
+22,000
+14% +$1.74M 0.15% 81
2013
Q4
$13.2M Sell
156,000
-6,000
-4% -$475K 0.15% 67
2013
Q3
$12.5M Buy
+162,000
New +$11.4M 0.16% 82

Other funds holding CELG

Virtu KCG Holdings's CELG Position: Q2 2017 in Review

Virtu KCG Holdings increased its Celgene Corp (CELG) stake by 116% in Q2 2017, buying an estimated $984K and bringing the position to 14,986 shares worth $1.95M. The position accounts for 0.05% of the portfolio, ranked #261.

Virtu KCG Holdings first reported a position in CELG in Q3 2013 and has held it in 16 quarters since. The position peaked at $10.7M in Q1 2014. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

  • Virtu KCG Holdings held 14,986 shares of Celgene Corp worth $1.95M as of Q2 2017.
  • Virtu KCG Holdings bought 8,034 Celgene Corp shares in Q2 2017, an estimated $984K.
  • Celgene Corp made up 0.05% of Virtu KCG Holdings's portfolio in Q2 2017, its #261 holding.
  • Virtu KCG Holdings first reported a position in Celgene Corp in Q3 2013 and has held it in 16 quarters since.
  • Virtu KCG Holdings's Celgene Corp position peaked at $10.7M in Q1 2014.
  • 1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.